- Title
- Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks
- Authors/Creators
- G. Koo (Author/Creator) - Vanderbilt University Medical CenterR. Yu (Author/Creator) - University of ChicagoE. Phillips (Author/Creator) - Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia 6150.C.A. Stone (Author/Creator) - Vanderbilt University Medical Center
- Publication Details
- The Journal of Allergy and Clinical Immunology: In Practice, Vol.10(9), pp.P2472-P2475
- Publisher
- Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
- Identifiers
- 991005542277207891
- Copyright
- © 2022 American Academy of Allergy, Asthma & Immunology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
Journal article
Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks
The Journal of Allergy and Clinical Immunology: In Practice, Vol.10(9), pp.P2472-P2475
2022
Details
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
8 File views/ downloads
73 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.265 Dermatology - Skin Allergies
- 1.265.1140 Drug Hypersensitivity
- Web Of Science research areas
- Allergy
- Immunology
- ESI research areas
- Clinical Medicine